Actively Recruiting
Preoperative Nicotine Cessation for Women With Breast Cancer Recommended for Reconstruction
Led by University of Florida · Updated on 2025-06-17
20
Participants Needed
1
Research Sites
224 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
Close to 20% of cancer patients currently use nicotine products. Nicotine use in breast cancer patients is associated with poorer overall outcomes, including worsened survival and increased surgical complications. Nicotine cessation is rarely addressed in breast cancer patients at the time of diagnosis and may be a missed opportunity to optimize patient outcomes. Patients that use nicotine products are not offered reconstruction at time of mastectomy or oncoplastics at the time of lumpectomy, which can be emotionally distressing in women with breast cancer. Reconstruction could be an additional motivating factor in nicotine cessation success. This study aims to evaluate the feasibility of a nicotine cessation program designed by Area Health Education Center (AHEC) in the target population. The study is designed to test the acceptability, and preliminary efficacy of a formal nicotine cessation program in women actively using nicotine products with breast cancer recommended for reconstructive or oncoplastics surgery.
CONDITIONS
Official Title
Preoperative Nicotine Cessation for Women With Breast Cancer Recommended for Reconstruction
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Adults 18 years of age and older and 80 years of age or younger
- Women diagnosed with Stage 0 to 3 breast cancer confirmed by biopsy
- Women recommended to have reconstruction at mastectomy or oncoplastic surgery at lumpectomy
- Active use of nicotine products within the past month
- Agree to follow all study procedures
You will not qualify if you...
- Not eligible for reconstruction or oncoplastic surgery due to BMI over 35, inflammatory breast cancer, or surgeon's decision
- Prisoners or individuals involuntarily detained for psychiatric or physical illness treatment
- Unable to complete sessions due to language, travel, or technology barriers
- Currently enrolled in another nicotine cessation program
- Pregnant patients
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
University of Florida
Gainesville, Florida, United States, 32608
Actively Recruiting
Research Team
J
Judy Walsh
CONTACT
How is the study designed?
Study Type
INTERVENTIONAL
Masking
NONE
Allocation
NA
Model
SINGLE_GROUP
Primary Purpose
TREATMENT
Number of Arms
1
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here